Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 5 Dec 2006 |
| Genmab, Capital increase in Genmab as a result of employee warrant exercise | 4 Dec 2006 |
| InvestorService: Genmab, to Present at Piper Jaffray 18th Annual Health Care Conference | 21 Nov 2006 |
| Genmab, Licenses MIF Receptor Target from Cytokine PharmaSciences | 20 Nov 2006 |
| Genmab, Roche Presents Positive Preclinical Data on Genmab Antibody | 8 Nov 2006 |